In the BioHarmony Drug Report Database
Von willebrand factor
Alphanate, Voncento (von willebrand factor human) is an unknown pharmaceutical. Von willebrand factor human was first approved as Alphanate on 2013-08-12. It has been approved in Europe to treat hemophilia a and von willebrand diseases.
Trade Name
|
Voncento |
|---|---|
Common Name
|
von willebrand factor human |
ChEMBL ID
|
CHEMBL4298126 |
Indication
|
hemophilia a, von willebrand diseases |
Drug Class
|
Image (chem structure or protein)
